# Relmada Therapeutics, Inc.: Form 10-Q for the period ended Feb 28, 2014

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 10-Q
- Filed: 2014-04-15
- Accepted by EDGAR: Apr 15, 2014, 12:35 ET
- Period: 2014-02-28
- Accession: 0001255294-14-000328
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000125529414000328/mainbody.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000125529414000328/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-02-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-12-01 to 2014-02-28 | $682 | us-gaap:Revenues |
| Revenue | 6 months, 2013-09-01 to 2014-02-28 | $2.5k | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-12-01 to 2014-02-28 | $685 | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2013-09-01 to 2014-02-28 | $2.4k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2013-12-01 to 2014-02-28 | −$3 | us-gaap:GrossProfit |
| Gross profit | 6 months, 2013-09-01 to 2014-02-28 | $161 | us-gaap:GrossProfit |
| Operating income | 3 months, 2013-12-01 to 2014-02-28 | −$3.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2013-09-01 to 2014-02-28 | −$17.5k | us-gaap:OperatingIncomeLoss |
| Net income | 6 months, 2013-09-01 to 2014-02-28 | −$17.5k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-12-01 to 2014-02-28 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2013-09-01 to 2014-02-28 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2013-09-01 to 2014-02-28 | −$12.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2014-02-28 | $2.6k | us-gaap:Cash |
| Current assets | at 2014-02-28 | $8.8k | us-gaap:AssetsCurrent |
| Total assets | at 2014-02-28 | $10.0k | us-gaap:Assets |
| Current liabilities | at 2014-02-28 | $41.2k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2014-02-28 | −$31.2k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000125529414000328/mainbody.htm

Filed Apr 15, 2014.
Source: SEC EDGAR, the filing index for accession 0001255294-14-000328. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.